InvestorsObserver
×
News Home

Can Haemonetics Corporation (HAE) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, May 12, 2022 02:44 PM | InvestorsObserver Analysts

Mentioned in this article

Can Haemonetics Corporation (HAE) Stock Rise to the Top of Healthcare Sector Thursday?

Haemonetics Corporation (HAE) is around the top of the Healthcare sector according to InvestorsObserver. HAE received an overall rating of 23, which means that it scores higher than 23% of stocks. Additionally, Haemonetics Corporation scored a 71 in the Healthcare sector, ranking it higher than 71% of stocks in that sector.

Overall Score - 23
HAE has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on HAE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 23 would rank higher than 23 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Haemonetics Corporation Stock Today?

Haemonetics Corporation (HAE) stock is trading at $50.64 as of 2:40 PM on Thursday, May 12, a decline of -$0.56, or -1.09% from the previous closing price of $51.20. The stock has traded between $50.50 and $52.68 so far today. Volume today is less active than usual. So far 385,055 shares have traded compared to average volume of 533,021 shares. Click Here to get the full Stock Report for Haemonetics Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App